Currently many pharmaceutical and biotechnology industry heavily invest in research and development sector gradually, Growth within the R&D expenditure by pharmaceutical & biotechnology companies and governments, including the increasing specialise in bioscience projects to develop new therapeutic & diagnostic products, is predicted to assist the clinical test imaging market.
In the healthcare industry, there's a big specialise in reducing growing healthcare costs; most industry stakeholders are undertaking various initiatives to form this possible. It’s difficult for imaging service providers to allocate significant capital for procuring high-cost equipment like advanced radiology and other imaging systems in such a scenario. The value of implementing an imaging system includes costs associated with procuring, housing, and maintaining equipment. These high upfront costs, including maintenance costs, tend to impact market growth negatively. to form optimal use of such equipment, imaging service providers got to hire expert professionals like experienced radiologists. Due to these factors, the implementation cost of imaging systems is extremely high, which may be a major factor restraining the expansion of the clinical test imaging market.
Covid-19 Impact on Clinical Trial Imaging Market:
In addition, this Global Market study offers an thorough analysis of this COVID-19 pandemic impact on the market growth and its influence on the long run growth of the worldwide Market. The recently published report demonstrates the elevation within the demand for the healthcare sector. The healthcare manufacturers have experienced future also as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for several healthcare products and services which are discussed intimately during this report. Moreover, the impact of this pandemic on overall market revenue for the bottom year 2020 and its projection up to 2027 is provided intimately during this report.
Clinical Trial Imaging Market Segment Overview
By Product and Services, The services section accounted for the biggest share of the clinical test imaging market in 2020, in the main owing to the rise in research and development, payment and growth in pharmaceutical and biotechnology industries.
By End User, the medicine section accounted for the biggest share. Factors like Increase in research and development payment and growth in pharmaceutical and biotechnology industries drive this market.
By Modality, the computerized tomography section accounted for the biggest share over the forecast period. Factors like increasing range of CROs, Increase in research and development payment and growth in pharmaceutical and biotechnology industries drive this market.
Market Analysis, Insights and Forecast – By Product and Service
· Trial Design Consulting Services
· Read Analysis Services
· Operational Imaging Services
· Imaging Software
Market Analysis, Insights and Forecast – By End User
· Pharmaceutical Companies
· Medical Device Manufacturers
· Academic and Government Research Institutes
· Other
Market Analysis, Insights and Forecast – By Modality
· Magnetic Resonance Imaging
· Computed Tomography
· Ultrasound
· Positron Emission Tomography
· X-Ray
· Echocardiography
· Other
Clinical Trial Imaging Market Regional Overview
Region-wise, in terms of regions, North America accounted for the biggest share of the clinical trial imaging market. The big share of this market segment is often attributed majorly to the presence of well-established CROs, rising R&D expenditure.
Clinical Trial Imaging Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Clinical Trial Imaging Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Clinical Trial Imaging are highlighted below.
· In 2021, IXICO Plc. Signed agreement with biopharmaceutical client IXICO to provide neuroimaging services for a Phase III clinical trial under this contract.
Clinical Trial Imaging Market, Key Players
· ICON plc.
· BioTelemetry Inc.
· Biomedical Systems Corporation
· Medpace Holdings, Inc.
· IXICO plc
· Resonance Health Ltd.
· Intrinsic Imaging LLC.
· Cardiovascular Imaging Technologies LLC.
· Medical Metrics Inc.
· Prism Clinical Imaging, Inc.
· Boston Imaging Core Lab LLC.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Clinical Trial Imaging Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product And Service
- 5.2.1. Trial Design Consulting Services
- 5.2.2. Read Analysis Services
- 5.2.3. Operational Imaging Services
- 5.2.4. Imaging Software
- 5.3. Market Analysis, Insights and Forecast – By End User
- 5.3.1. Pharmaceutical Companies
- 5.3.2. Medical Device Manufacturers
- 5.3.3. Academic and Government Research Institutes
- 5.3.4. Other
- 5.4. Market Analysis, Insights and Forecast – By Modality
- 5.4.1. Magnetic Resonance Imaging
- 5.4.2. Computed Tomography
- 5.4.3. Ultrasound
- 5.4.4. Positron Emission Tomography
- 5.4.5. X-Ray
- 5.4.6. Echocardiography
- 5.4.7. Other
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East, and Africa
6. North America Clinical Trial Imaging Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product And Service
- 6.2.1. Trial Design Consulting Services
- 6.2.2. Read Analysis Services
- 6.2.3. Operational Imaging Services
- 6.2.4. Imaging Software
- 6.3. Market Analysis, Insights and Forecast – By End User
- 6.3.1. Pharmaceutical Companies
- 6.3.2. Medical Device Manufacturers
- 6.3.3. Academic and Government Research Institutes
- 6.3.4. Other
- 6.4. Market Analysis, Insights and Forecast – By Modality
- 6.4.1. Magnetic Resonance Imaging
- 6.4.2. Computed Tomography
- 6.4.3. Ultrasound
- 6.4.4. Positron Emission Tomography
- 6.4.5. X-Ray
- 6.4.6. Echocardiography
- 6.4.7. Other
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Clinical Trial Imaging Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product And Service
- 7.2.1. Trial Design Consulting Services
- 7.2.2. Read Analysis Services
- 7.2.3. Operational Imaging Services
- 7.2.4. Imaging Software
- 7.3. Market Analysis, Insights and Forecast – By End User
- 7.3.1. Pharmaceutical Companies
- 7.3.2. Medical Device Manufacturers
- 7.3.3. Academic and Government Research Institutes
- 7.3.4. Other
- 7.4. Market Analysis, Insights and Forecast – By Modality
- 7.4.1. Magnetic Resonance Imaging
- 7.4.2. Computed Tomography
- 7.4.3. Ultrasound
- 7.4.4. Positron Emission Tomography
- 7.4.5. X-Ray
- 7.4.6. Echocardiography
- 7.4.7. Other
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Clinical Trial Imaging Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product And Service
- 8.2.1. Trial Design Consulting Services
- 8.2.2. Read Analysis Services
- 8.2.3. Operational Imaging Services
- 8.2.4. Imaging Software
- 8.3. Market Analysis, Insights and Forecast – By End User
- 8.3.1. Pharmaceutical Companies
- 8.3.2. Medical Device Manufacturers
- 8.3.3. Academic and Government Research Institutes
- 8.3.4. Other
- 8.4. Market Analysis, Insights and Forecast – By Modality
- 8.4.1. Magnetic Resonance Imaging
- 8.4.2. Computed Tomography
- 8.4.3. Ultrasound
- 8.4.4. Positron Emission Tomography
- 8.4.5. X-Ray
- 8.4.6. Echocardiography
- 8.4.7. Other
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Clinical Trial Imaging Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product And Service
- 9.2.1. Trial Design Consulting Services
- 9.2.2. Read Analysis Services
- 9.2.3. Operational Imaging Services
- 9.2.4. Imaging Software
- 9.3. Market Analysis, Insights and Forecast – By End User
- 9.3.1. Pharmaceutical Companies
- 9.3.2. Medical Device Manufacturers
- 9.3.3. Academic and Government Research Institutes
- 9.3.4. Other
- 9.4. Market Analysis, Insights and Forecast – By Modality
- 9.4.1. Magnetic Resonance Imaging
- 9.4.2. Computed Tomography
- 9.4.3. Ultrasound
- 9.4.4. Positron Emission Tomography
- 9.4.5. X-Ray
- 9.4.6. Echocardiography
- 9.4.7. Other
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. IXICO plc
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. ICON plc.
- 10.6. BioTelemetry Inc.
- 10.7. Biomedical Systems Corporation
- 10.8. Medpace Holdings, Inc.
- 10.9. Resonance Health Ltd.
- 10.10. Intrinsic Imaging LLC.
- 10.11. Cardiovascular Imaging Technologies LLC.
- 10.12. Medical Metrics Inc.
- 10.13. Prism Clinical Imaging, Inc.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
